Search details
1.
Omicron extensively but incompletely escapes Pfizer BNT162b2 neutralization.
Nature
; 602(7898): 654-656, 2022 02.
Article
in English
| MEDLINE | ID: mdl-35016196
2.
Omicron infection enhances Delta antibody immunity in vaccinated persons.
Nature
; 607(7918): 356-359, 2022 07.
Article
in English
| MEDLINE | ID: mdl-35523247
3.
Escape of SARS-CoV-2 501Y.V2 from neutralization by convalescent plasma.
Nature
; 593(7857): 142-146, 2021 05.
Article
in English
| MEDLINE | ID: mdl-33780970
4.
T cell derived HIV-1 is present in the CSF in the face of suppressive antiretroviral therapy.
PLoS Pathog
; 17(9): e1009871, 2021 09.
Article
in English
| MEDLINE | ID: mdl-34555123
5.
Immunogenicity of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Infection and Ad26.CoV2.S Vaccination in People Living With Human Immunodeficiency Virus (HIV).
Clin Infect Dis
; 75(1): e857-e864, 2022 08 24.
Article
in English
| MEDLINE | ID: mdl-34893824
6.
Interference with HIV infection of the first cell is essential for viral clearance at sub-optimal levels of drug inhibition.
PLoS Comput Biol
; 16(2): e1007482, 2020 02.
Article
in English
| MEDLINE | ID: mdl-32017770
7.
HIV Cell-to-Cell Spread Results in Earlier Onset of Viral Gene Expression by Multiple Infections per Cell.
PLoS Pathog
; 12(11): e1005964, 2016 Nov.
Article
in English
| MEDLINE | ID: mdl-27812216
8.
Trichomonas vaginalis exosomes deliver cargo to host cells and mediate hostâ¶parasite interactions.
PLoS Pathog
; 9(7): e1003482, 2013.
Article
in English
| MEDLINE | ID: mdl-23853596
9.
SARS-CoV-2 infection in immunosuppression evolves sub-lineages which independently accumulate neutralization escape mutations.
Virus Evol
; 10(1): vead075, 2024.
Article
in English
| MEDLINE | ID: mdl-38361824
10.
Clearance of persistent SARS-CoV-2 associates with increased neutralizing antibodies in advanced HIV disease post-ART initiation.
Nat Commun
; 15(1): 2360, 2024 Mar 15.
Article
in English
| MEDLINE | ID: mdl-38491050
11.
Safety and immunogenicity of booster vaccination and fractional dosing with Ad26.COV2.S or BNT162b2 in Ad26.COV2.S-vaccinated participants.
PLOS Glob Public Health
; 4(4): e0002703, 2024.
Article
in English
| MEDLINE | ID: mdl-38603677
12.
Trichomonas vaginalis contact-dependent cytolysis of epithelial cells.
Infect Immun
; 81(5): 1411-9, 2013 May.
Article
in English
| MEDLINE | ID: mdl-23429535
13.
Field evaluations of four SARS-CoV-2 rapid antigen tests during SARS-CoV-2 Delta variant wave in South Africa.
Diagn Progn Res
; 7(1): 14, 2023 Jul 25.
Article
in English
| MEDLINE | ID: mdl-37491317
14.
Performance of rapid antigen tests in identifying Omicron BA.4 and BA.5 infections in South Africa.
J Clin Virol
; 165: 105498, 2023 08.
Article
in English
| MEDLINE | ID: mdl-37329842
15.
Evolution and neutralization escape of the SARS-CoV-2 BA.2.86 subvariant.
Nat Commun
; 14(1): 8078, 2023 Dec 06.
Article
in English
| MEDLINE | ID: mdl-38057313
16.
Safety and immunogenicity of booster vaccination and fractional dosing with Ad26.COV2.S or BNT162b2 in Ad26.COV2.S-vaccinated participants.
medRxiv
; 2023 Nov 20.
Article
in English
| MEDLINE | ID: mdl-38045321
17.
SARS-CoV-2 evolves increased infection elicited cell death and fusion in an immunosuppressed individual.
medRxiv
; 2022 Nov 30.
Article
in English
| MEDLINE | ID: mdl-36451879
18.
Omicron BA.4/BA.5 escape neutralizing immunity elicited by BA.1 infection.
Nat Commun
; 13(1): 4686, 2022 08 10.
Article
in English
| MEDLINE | ID: mdl-35948557
19.
Omicron infection of vaccinated individuals enhances neutralizing immunity against the Delta variant.
medRxiv
; 2022 Jan 28.
Article
in English
| MEDLINE | ID: mdl-34981076
20.
SARS-CoV-2 prolonged infection during advanced HIV disease evolves extensive immune escape.
Cell Host Microbe
; 30(2): 154-162.e5, 2022 02 09.
Article
in English
| MEDLINE | ID: mdl-35120605